Philip Morris To Part With Inhaler Maker In Up To £258M Deal
By Law360 Staff · September 17, 2024, 2:53 PM EDT
Philip Morris International is spacing itself from the British inhaler maker it purchased in 2021 through an up to £258 million ($339.6 million) sale that preserves a commercial relationship, amid what...
To view the full article, register now.